Frontiers in Pharmacology (Mar 2022)

New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis

  • Su Yin Koay,
  • Daniel F. P. Larkin

DOI
https://doi.org/10.3389/fphar.2022.796854
Journal volume & issue
Vol. 13

Abstract

Read online

Neurotrophic keratitis (NK) is a rare degenerative condition that is caused by damage to the trigeminal nerve, with partial or complete loss of corneal sensory innervation. The loss of innervation leads to impaired healing of corneal epithelium, which subsequently results in punctate epithelial erosions, persistent epithelial defects, corneal ulcers and corneal perforation. Management of NK is often supportive and aims to promote epithelial healing and prevent progression of disease. Multiple novel pharmacological approaches have been proposed to address the underlying pathophysiology of NK, which are discussed in this paper.

Keywords